In this blog, Lana El-Etr examines the legal and ethical implications of patenting fully synthetic minimal cells, organisms engineered with only the essential genes for life. While a few Supreme Court decisions provide some guidance, this blog argues for updated patent standards that clearly define what qualifies as synthetic and patentable, guard against monopolization of foundational biological tools, and promote equitable access to medical and biotechnological advancements.